The surveillance, epidemiology, and end results program: A national resource

Cancer Epidemiology Biomarkers and Prevention

Volumn 8, Issue 12, 1999, Pages 1117-1121

  Hankey, Benjamin F ^a   Ries, Lynn A ^a   Edwards, Brenda K ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CANCER STATISTICS; DATA BASE; GEOGRAPHIC DISTRIBUTION; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW;

DATA INTERPRETATION, STATISTICAL; DATABASES, FACTUAL; HUMANS; NATIONAL INSTITUTES OF HEALTH (U.S.); NEOPLASMS; ORGANIZATIONAL OBJECTIVES; POPULATION SURVEILLANCE; PUBLISHING; RESEARCH; SEER PROGRAM; UNITED STATES;

EID: 0033406355     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Cutler, S. J., and Young, J. L. (eds.). Third National Cancer Survey: Incidence Data. National Cancer Institute Monograph 41, Department of Health, Education and Welfare Publ. No.75-787. Bethesda, MD: National Cancer Institute, 1975.
2. Frey, C. M., McMillen, M., Cowan, C. D., Horm, J. W., and Kessler, L. G. Representativeness of the Surveillance, Epidemiology, and End Results Program data: recent trends in cancer mortality rates. J. Natl. Cancer Inst., 84: 872-877, 1992.
3. Ries, L. A. G., Kosary, C. L., Hankey, B. F., Miller, B. A., and Edwards, B. K. SEER Cancer Statistics Review, 1973-1996. Bethesda, MD: National Cancer Institute, 1999.
4. Percy, C. (ed.). Histology of cancer incidence and prognosis: SEER population-based data, 1973-1987. Cancer (Phila.), 75: 139-419, 1995.
5. Miller, B. A., Kolonel, L. N., Bernstein, L., Young, J. L., Jr., Swanson, G. M., West, D., Key, C. R., Liff, J. M., Glover, C. S., and Alexander, G. A. Racial/ ethnic patterns of cancer in the United States 1988-1992. Bethesda, MD: National Cancer Institute, 1996.
6. Stanford, J. L., Stephenson, R. A., Coyle, L. M., Cerhan, J., Correa, R., Eley, J. W., Gilliland, F., Hankey, B., Kolonel, L. N., Kosary, C., Ross, R., Severson, R., and West, D. Prostate Cancer Trends 1973-1995, SEER Program. Bethesda, MD: National Cancer Institute, 1998.
7. Hankey, B. F., Feuer, E. J., Clegg, L. X., Hayes, R. B., Legler, J. M., Prorok, P. C., Ries, L. A., Merrill, R. M., and Kaplan, R. S. Interpreting trends in prostate cancer. Part I. Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J. Natl. Cancer Inst., 91: 1017-1024, 1999.
8. Feuer, E. J., Merrill, R. M., and Hankey, B. F. Interpreting trends in prostate cancer. Part II. Cause of death misclassification and the recent rise and fall in prostate cancer mortality. J. Natl. Cancer Inst., 91: 1025-1032, 1999.
9. Etzioni, R., Legler, J. M., Feuer, E. J., Merrill, R. M., Cronin, K., and Hankey, B. F. Interpreting trends in prostate cancer. Part III. Quantifying the link between population PSA testing and recent declines in prostate cancer mortality. J. Natl. Cancer Inst., 91: 1033-1039, 1999.
10. Wingo, P. A., Ries, L. A., Giovino, G. A., Miller, D. S., Rosenberg, H. M., Shopland, D. R., Thun, M. J., and Edwards, B. K. Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. J. Natl. Cancer Inst., 91: 675-690, 1999.
11. Legler, J. M., Feuer, E. J., Potosky, A. L., Merrill, R. M., and Kramer, B. S. The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence decline in the United States. Cancer Causes Control, 9: 519-527, 1998.
12. Devesa, S. S., Blot, W. J., and Fraumeni, J. F. J. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer (Phila.), 83: 2049-2053, 1998.
13. Gail, M., and Rimer, B. Risk-based recommendations for mammographic screening for women in their forties. J. Clin. Oncol., 16: 3105-3114, 1998.
14. Klabunde, C. N., Potosky, A. L., Harlan, L. C., and Kramer, B. S. Trends and black/white differences in treatment for nonmetastatic prostate cancer. Med. Care (Phila.), 36: 1337-1348, 1998.
15. Travis, L. B., Curtis, R. E., Storm, H., Hall, P., Holowaty, E., Van Leeuwen, F. E., Kohler, B. A., Pukkala, E., Lynch, C. F., Andersson, M., Bergfeldt, K., Clarke, E. A., Wiklund, T., Stoter, G., Gospodarowicz, M., Sturgeon, J., Fraumeni, J. F. J., and Boice, J. D. J. Risk of second malignant neoplasms among long-term survivors of testicular cancer. J. Natl. Cancer Inst., 89: 1429-1439, 1997.
16. Etzioni, R., Cha, R., Feuer, E. J., and Davidov, O. Asymptomatic incidence and duration of prostate cancer. Am. J. Epidemiol., 148: 775-785, 1998.
17. Kulldorff, M., Athas, W. F., Feurer, E. J., Miller, B. A., and Key, C. R. Evaluating cluster alarms: a space-time scan statistic and brain cancer in Los Alamos, New Mexico. Am. J. Public Health, 88: 1377-1380, 1998.
18. Wun, L. M., Merrill, R. M., and Feuer, E. J. Estimating lifetime and age-conditional probabilities of developing cancer. Lifetime Data Anal., 4: 169-186, 1998.
19. Rosenberg, R. D., Lando, J. F., Hunt, W. C., Darling, R. R., Williamson, M. R., Linver, M. N., Gilliland, F. D., and Key, C. R. The New Mexico Mammography Project. Screening mammography performance in Albuquerque, New Mexico, 1991 to 1993. Cancer (Phila.), 78: 1731-1739, 1996.
20. Albertsen, P. C., Nease, R. F. J., and Potosky, A. L. Assessment of patient preferences among men with prostate cancer. J. Urol., 159: 158-163, 1998.
21. Polednak, A. P., Shevchenko, I. P., and Flannery, J. T. Estimating breast cancer treatment charges in Connecticut. Conn. Med., 60: 263-267, 1996.
22. Polednak, A. P., Schevchenko, I. P., and Flannery, J. T. Estimating cancer incidence using a hospital discharge database versus a tumor registry. J. Registry Management, 24: 25-28, 1997.
23. Polednak, A. P. Comorbidity and mortality of breast cancer patients diagnosed before age 65. J. Registry Management, in press, 1999.
24. Etzioni, R., and Thompson, I. M. Prostate cancer and computer models: background, limitations, and potential. Urol. Oncol., 2: 57-64, 1996.
25. Etzioni, R., and Shen, Y. Estimating asymptomatic duration in cancer: the AIDS connection. Stat. Med., 16: 627-644, 1997.
26. Etzioni, R., Shen, Y., Petteway, J. C., and Brawer, M. K. Age-specific prostate-specific antigen: a reassessment. Prostate Suppl., 7: 70-77, 1996.
27. Ramsey, S. D., Etzioni, R., Troxel, A., and Urban, N. Optimizing sampling strategies for estimating quality-adjusted life years. Med Decis. Making, 17: 431-438, 1997.
28. Urban, N., Drescher, C., Etzioni, R., and Colby, C. Use of a stochastic simulation model to identify an efficient protocol for ovarian cancer screening. Controlled Clin. Trials, 18: 251-270, 1997.
29. Lin, D. Y., Feuer, E. J., Etzioni, R., and Wax, Y. Estimating medical costs from incomplete follow-up data. Biometrics, 53: 419-434, 1997.
30. Etzioni, R., Urban, N., and Baker, M. Estimating the costs attributable to a disease with application to ovarian cancer. J. Clin. Epidemiol., 49: 95-103, 1996.
31. Fireman, B. H., Quesenberry, C. P., Somkin, C. P., Jacobson, A. S., Baer, D., West, D., Potosky, A. L., and Brown, M. L. Cost of care for cancer in a health maintenance organization. Health Care Financ. Rev., 18: 51-76, 1997.
32. Swallen, K. C., West, D. W., Stewart, S. L., Glaser, S. L., and Horn-Ross, P.L. Misclassification of Hispanic ethnicity in a population-based cancer registry. Ann. Epidemiol., 7: 200-206, 1997.
33. Stewart, S. L., Swallen, K. C., Glaser, S. L., Horn-Ross, P. L., and West, D. W. Adjustment of cancer incidence rates for ethnic misclassification. Biometrics, 54: 774-781, 1998.
34. Stewart, S. L., Swallen, K. C., Glaser, S. L., Horn-Ross, P. L., and West, D. W. Comparison of methods to classify Hispanic ethnicity in a population-based cancer registry. Am. J. Epidemiol., 149: 1063-1071, 1998.
35. Platz, C. E., Cohen, M. B., Jones, M. P., Olson, D. B., and Lynch, C. F. Is microstaging of early invasive cancer of the urinary bladder possible or useful? Mod. Pathol., 9: 1035-1039, 1996.
36. Yancik, R., Havlik, R. J., Wesley, M. N., Ries, L., Long, S., Rossi, W. K., and Edwards, B. K. Cancer and comorbidity in older patients: a descriptive profile. Ann. Epidemiol., 6: 399-412, 1996.
37. Yancik, R. Cancer burden in the aged: an epidemiologic and demographic overview. Cancer (Phila.), 80: 1273-1283, 1997.
38. Yancik, R., Wesley, M. N., Ries, L. A., Havlik, R. J., Long, S., Edwards, B. K., and Yates, J. W. Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study. Cancer (Phila.), 82: 2123-2134, 1998.
39. Ballard-Barbash, R., Taplin, S. H., Yankaskas, B. C., Ernster, V. L., Rosenberg, R. D., Carney, P. A., Barlow, W. E., Geller, B. M., Kerlikowske, K., Edwards, B. K., Lynch, C. F., Urban, N., Chrvala, C. A., Key, C. R., Poplack, S. P., Worden, J. K., and Kessler, L. G. Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database. Am. J. Roentgenol., 169: 1001-1008, 1997.
40. Kim, H. J., Fay, M. P., Feuer, E. J., and Midthune, D. N. Permutation tests for joinpoint regression with applications to cancer rates. Stat. Med., in press, 1999.
41. Hankey, B. F., Ries, L. A., Kosary, C. L., Feuer, E. J., Merrill, R. M., Clegg, L. X., and Edwards, B. K. Partitioning linear trends in age-adjusted rates. Cancer Causes Control, in press, 1999.
42. Chu, K. C., Miller, B. A., Feuer, E. J., and Hankey, B. F. A method for partitioning cancer mortality trends by factors associated with diagnosis: an application to female breast cancer. J. Clin. Epidemiol., 47: 1451-1461, 1994.
43. Surveillance Implementation Group. Cancer Surveillance Research Implementation Plan. Bethesda, MD: National Cancer Institute, NIH, 1999.